0.32
+0.0036(+1.14%)
Currency In USD
| Previous Close | 0.32 |
| Open | 0.33 |
| Day High | 0.35 |
| Day Low | 0.3 |
| 52-Week High | 2.5 |
| 52-Week Low | 0.13 |
| Volume | 671,894 |
| Average Volume | 1.75M |
| Market Cap | 24.19M |
| PE | -0.42 |
| EPS | -0.77 |
| Moving Average 50 Days | 0.24 |
| Moving Average 200 Days | 0.57 |
| Change | 0 |
If you invested $1000 in The Oncology Institute, Inc. (TOI) since IPO date, it would be worth $33 as of December 30, 2024 at a share price of $0.32. Whereas If you bought $1000 worth of The Oncology Institute, Inc. (TOI) shares 3 years ago, it would be worth $35.21 as of December 30, 2024 at a share price of $0.32.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Florida Blue enhances cancer care for thousands of members
GlobeNewswire Inc.
Dec 18, 2024 9:05 PM GMT
New program aims to improve patient outcomes, experience, and quality of life by streamlining access to affordable and high-quality oncology careJACKSONVILLE, Fla., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Florida Blue, the state's leading health insurer,
The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California
GlobeNewswire Inc.
Nov 11, 2024 1:00 PM GMT
TOI will be one of the few community-based practices on the West Coast to offer radiopharmaceuticals in the outpatient setting.CERRITOS, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI)
The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call
GlobeNewswire Inc.
Nov 05, 2024 12:09 AM GMT
CERRITOS, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its third quarter 2024 financia